三种镇痛方法治疗肋骨骨折的初步研究
这项初步研究将55岁以上、至少三处单侧肋骨骨折患者随机分入竖脊肌平面(ESP)导管、利多卡因输注或多模式镇痛组,主要结局为平均疼痛评分和阿片类药物消耗。结果显示各组疼痛评分和阿片类药物消耗无差异,但利多卡因组有三人出现可能的局部麻醉药全身毒性(LAST),对照组肺炎更常见,ESP组谵妄更少。
要点
- ESP阻滞、利多卡因输注与多模式镇痛在疼痛评分和阿片消耗上无显著差异。
- 利多卡因组有3例出现可能的LAST症状,老年患者需系统评估。
- 肺炎和谵妄可能是未来确定性试验的优选终点。
核心结论
- 三种镇痛方法的镇痛效果相当,不能排除ESP阻滞或利多卡因输注有 modest 早期镇痛获益。
- 肺炎或谵妄可能是未来确定性试验的优选终点。
- 利多卡因组出现可能的LAST症状,未来试验应系统评估,尤其是老年患者。
研究设计与样本
- 初步研究,随机分配患者至ESP导管、利多卡因输注或多模式镇痛组。
- 主要结局为平均疼痛评分和阿片类药物消耗,评估72小时。
主要发现
- 第1天平均疼痛评分:ESP组4.9±3.1,利多卡因组5.8±3.1,对照组5.6±3.3。
- 第2天平均疼痛评分:ESP组4.4±3.3,利多卡因组5.4±3.0,对照组7.4±2.6。
- 第3天平均疼痛评分:ESP组4.4±2.1,利多卡因组5.8±2.6,对照组5.2±3.5,p=0.70。
- 阿片类药物消耗中位数[IQR]:ESP组25.0[66.8],利多卡因组26.7[89.2],对照组20.0[101.4],p=0.68。
- 利多卡因组3例出现可能的LAST症状,对照组肺炎更常见,ESP组谵妄更少。
关键数值与推荐
- 招募率每月2.4例患者,2例退出。
临床怎么用
- 对于老年肋骨骨折患者,三种镇痛方法均可选择,但利多卡因输注需警惕LAST。
- ESP阻滞可能减少谵妄,但需进一步验证。
局限性
- 2例患者在30天评估前死亡。
- 利多卡因组出现可能的LAST症状,需系统评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rib fractures in the elderly are associated with pulmonary complications and mortality. The erector spinae plane (ESP) block might reduce pain and improve pulmonary function. Lidocaine infusions offer a non-invasive alternative delivery of local anesthetic. This pilot study was designed to inform the design of a future large trial. METHODS: Patients ≥ 55 years of age with at least three unilateral rib fractures were randomly assigned to an ESP catheter, lidocaine infusion, or multimodal analgesia alone. Baseline measurements included the Duke Activity Status Index (DASI) score. Pain, opioid use, adverse effects, vital capacity, delirium, and sedation were assessed for 72 hours. Primary outcomes were average pain ratings and opioid consumption. Pulmonary complications, opioid use, functional status, and safety outcomes were assessed to determine feasibility of a definitive trial. RESULTS: Twenty-four patients were included in analyses. Demographics and injury severity were similar. The recruitment rate was 2.4 patients per month with two patients withdrawals. The mean ± SD pain ratings did not differ between ESP, lidocaine, and control groups, respectively (day 1: (4.9 ± 3.1 versus 5.8 ± 3.1 versus 5.6 ± 3.3); day 2: (4.4 ± 3.3 versus 5.4 ± 3.0 versus 7.4 ± 2.6); and day 3: (4.4 ± 2.1 versus 5.8 ± 2.6 versus 5.2 ± 3.5; p=0.70). Median [IQR] opioid consumption did not differ between the same groups, respectively (25.0 [66.8] versus 26.7 [89.2] versus 20.0 [101.4]; p=0.68). Three lidocaine patients experienced possible local anesthetic systemic toxicity (LAST) despite our conservative dosing protocol. Two patients died before the 30-day assessments. Pneumonia occurred more frequently in controls and could be a future 4 primary outcome for a definitive trial, which would require enrolling 11 patients per month over three years. Delirium occurred less frequently in ESP patients. CONCLUSIONS: Analgesia was comparable between groups. While this study does not rule out a modest early analgesic benefit of ESP block or lidocaine infusion, pulmonary complications or delirium may be the preferred endpoint. Possible LAST symptoms occurred in three lidocaine patients despite conservative dosing and should be systematically assessed in future trials, especially in the elderly.
引用
- Schwenk ES, Bloom R, Torjman MC, et al. Pilot study comparing three analgesia approaches for rib fractures. Reg Anesth Pain Med. 2026. PMID: 42161395. doi:10.1136/rapm-2026-107865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。